Navigation Links
Amsterdam Native and St. Jude Patient Christian Gizara to Appear With Marlo Thomas on Dec. 8 'Larry King Live' to Educate Viewers About Life-Saving Work of St. Jude Children's Research Hospital(R)
Date:11/30/2007

Appearance part of Fourth Annual St. Jude Thanks and Giving(R) Campaign

AMSTERDAM, N.Y., Nov. 28 /PRNewswire-USNewswire/ -- Twelve-year-old Christian Gizara, Amsterdam native and St. Jude patient, will appear alongside St. Jude National Outreach Director Marlo Thomas during the December 8th episode of "Larry King Live." This appearance, which can be seen Saturday, December 8th at 9 p.m. ET on CNN, is one in a series of media activities in conjunction with the fourth annual St. Jude Thanks and Giving campaign. Christian, who was diagnosed with ependymoma, a brain tumor, in 2003 and is now cancer-free, will share his story on-air and help educate viewers about the life-saving work of St. Jude and how they can help by participating in the Thanks and Giving campaign.

This is the third year for long-time St. Jude supporter, Larry King, to invite Marlo Thomas to share stories of hope, like Christian's, with his viewers during Thanks and Giving. Christian's story is a unique one -- it began in October 2003 when Christian developed flu-like symptoms. His parents took him to see their pediatrician, who suggested rest and fluids. But three days later, Christian woke up vomiting and crying that his head hurt "really bad." His doctor sent him for an MRI and lab work at the local children's hospital, where Christian was diagnosed with ependymoma, a brain tumor. Two days after his diagnosis, Christian underwent a nine-hour brain surgery to remove the tumor. Knowing he needed ongoing treatment, his parents searched the Internet, where they discovered St. Jude. Tune in Saturday, December 8th to hear the rest of Christian's story, how St. Jude saved his life and see how he's doing today.

This holiday season, everyone can help kids like Christian by supporting the Thanks and Giving campaign. The campaign encourages customers to "Give thanks for the healthy kids in your life, and give to those who are not." Shoppers will see the St. Jude Thanks and Giving mag
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
2. Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008
3. Amsterdam Native and St. Jude Patient Christian Gizara to Appear With Marlo Thomas on Nov. 30 Larry King Live to Educate Viewers About Life-Saving Work of St. Jude Childrens Research Hospital(R)
4. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
5. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
6. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
7. Trade-offs reveal no clear favorites in alternative energy market
8. Clinical trials present better alternatives for dialysis patients
9. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
10. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
11. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... Lake City, Utah (PRWEB) July 12, 2014 ... spotlighted two types of startups, with awards being bestowed ... new emphasis spotlighted Utah’s outstanding entrepreneur community with recognition ... proving a sustainable model with incoming revenue. , 25 ... from across the state that are under 5 years ...
(Date:7/12/2014)... article released by Seattle's well known plastic surgeon, Dr. Bryan ... cosmetic surgical procedures in summer months . , As ... enliven the rainy Pacific Northwest, many people are turning their ... out as much during the winter as they had planned. ... eager to look their best for their summer vacations, and ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Wright & Schulte ... clients in Just For Men Lawsuits (case #59776/2014), announces ... consumers of reports that allege the popular hair dye, Just ... burns to their face, neck and other areas. In addition ... For Men chemical burns , the advertisements being run by ...
(Date:7/12/2014)... July 12, 2014 Floor-grade ... of 4.1 out of 5. This above-average score ... been underpinning buyer negotiation power over the three ... Anna Son, “during the period, surging demand for ... associated with new product development, have placed upward ...
(Date:7/12/2014)... 12, 2014 The largest pure occupational ... pleased to announce that it will be opening its ... facility will join four Atlanta-based Nova Medical Centers’ locations. ... 3209 Deans Bridge Road, and will be open from ... , “With Nova’s treatment philosophy of rapid return-to-work and ...
Breaking Medicine News(10 mins):Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Best Summer Cosmetic Surgeries Revealed in Article By Seattle Plastic Surgeon 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2
... intervention may be more effective, researchers say , , SUNDAY, ... rheumatoid arthritis could be identified and enrolled in clinical ... type of assessment and excluded two traditional assessments, according ... at 292 people, average age 54, seen at the ...
... at American Academy of Ophthalmology Annual Meeting Examines ... Glaucoma as Manifestation of a Larger Disease, NEW ORLEANS, ... the eye. For most of the 20th century, it was ... an,increasing number of non-pressure-dependent risk factors have been,identified, suggesting that ...
... Showed That Over a 6 Month Period, Nasacort AQ ... Significant Adrenal Suppression in This Same Age ... at,the American College of Allergy, Asthma & Immunology (ACAAI) ... Nasal Spray may be used safely and effectively to ...
... factor, study finds, urging greater outreach to bridge racial gap ... from transplant centers doesn,t explain why black Americans with end-stage ... placed on the kidney transplant waiting list, researchers say. ... end-stage renal (kidney) disease patients in Georgia and the Carolinas ...
... 9 Four members of the same,family, who ... Medicare Equipment,(DME) companies and Comprehensive Outpatient Rehabilitation Facilities ... for Medicare fraud, Assistant,Attorney General Alice S. Fisher ... Acosta of the Southern District of Florida announced ...
... Nov. 9 After several years of litigation,Merck has ... Vioxx. The,medication was pulled off the market in 2004 ... heart attacks and strokes. It is one of the,largest ... Smiljanich is pleased this long process is,coming to a ...
Cached Medicine News:Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2Health News:Looking at Glaucoma as a Systemic Disease 2Health News:Looking at Glaucoma as a Systemic Disease 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6Health News:Blacks in Poor Areas Less Likely to Be On Kidney Transplant Lists 2Health News:Four Miami Health Care Company Owners Sentenced to 57 Months in Prison For Medicare Fraud 2
(Date:7/10/2014)... 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... has completed the sale to Galderma of all rights ... held by Valeant for $1.4 billion in cash, pursuant ... recently completed its acquisition of Galderma. ... products to a company that is firmly committed to ...
(Date:7/10/2014)... Decision Resources Group finds that over half ... and Drug Administration,s (FDA) approval of Vifor Fresenius Medical ... approved by the FDA in November 2013 for the ... on dialysis. Other key findings from the ... : , Bundling: ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... 8 Lixte,Biotechnology Holdings, Inc. (OTC Bulletin Board: ... two different types of drugs being,developed as potential ... against human pancreatic cancers in a mouse model., ... of Lixte, said, "Lixte previously,reported that lead compounds ...
... Wash., Aug. 7 ProteoTech Inc. (ProteoTech),today announced ... requirements and has been cleared by the FDA ... Exebryl-1(R), a novel small molecule drug targeting,toxic beta-amyloid ... initiated its Phase 1 human trial on July ...
Cached Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease 2
A unique and cost effective one-piece adhesive closure patient bracelet with a tamper- resistant feature that has been designed for patient comfort, caregiver productivity, and long term durability....
The IDENTI-PRINT II ID system functions as a complete, hospital wide patient identification system. It integrates the benefits of bedside labeling into a multipurpose ID band that consolidates admitt...
... The AeroScout Location Receiver is an ... Visibility System to outdoor and difficult ... and sophisticated location measurement capabilities packaged ... designed for harsh conditions. The Location ...
... facilitates real time information collection. It ... first module is a software link ... the database where information is captured ... the user interface, which allows access ...
Medicine Products: